Matthieu Vermeren

Matthieu Vermeren

Auto-generated profile, based on publicly available information

Matthieu Vermeren

Centre for Inflammation Research, Institute for Regeneration and Repair, The University of Edinburgh, Edinburgh, UK

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 August 2004 in Nature Neuroscience
Verified
Journal Article
Closed access
PDF file
GMGéraldine S Maro
Géraldine S Maro
MVMatthieu Vermeren
Matthieu Vermeren
OVOctavian Voiculescu
Octavian Voiculescu
LMLisa Melton
Lisa Melton
JCJames Cohen
James Cohen
PTPiotr Topilko
Piotr Topilko

30 October 2007 in Neural Development
Verified
Journal Article
Open access
PDF file
RBRomke Bron
Romke Bron
MVMatthieu Vermeren
Matthieu Vermeren
NKNatalie Kokot
Natalie Kokot
WAWilliam Andrews
William Andrews
GLGraham E Little
Graham E Little
JCJames Cohen
James Cohen
Background: In developing neurons, somal migration and initiation of axon outgrowth often occur simultaneously and are regulated in part by similar classes of molecules. When neurons reach their final destinations, however, somal translocation and axon extension are uncoupled. Insights into the mechanisms underlying this process of disengagement came from our study of the behaviour of embryonic spinal motor neurons following ablation of boundary cap cells. These are neural crest derivatives that transiently reside at motor exit points, central nervous system (CNS):peripheral nervous system (PNS) interfaces where motor axons leave the CNS. In the absence of boundary cap cells, motor neuron cell bodies migrate along their axons into the periphery, suggesting that repellent signals from boundary cap cells regulate the selective gating of somal migration and axon outgrowth at the motor exit point. Here we used RNA interference in the chick embryo together with analysis of null mutant mice to identify possible boundary cap cell ligands, their receptors on motor neurons and cytoplasmic signalling molecules that control this process. Results: We demonstrate that targeted knock down in motor neurons of Neuropilin-2 (Npn-2), a high affinity receptor for class 3 semaphorins, causes their somata to migrate to ectopic positions in ventral nerve roots. This finding was corroborated in Npn-2 null mice, in which we identified motor neuron cell bodies in ectopic positions in the PNS. Our RNA interference studies further revealed a role for Plexin-A2, but not Plexin-A1 or Plexin-A4. We show that chick and mouse boundary cap cells express Sema3B and 3G, secreted semaphorins, and Sema6A, a transmembrane semaphorin. However, no increased numbers of ectopic motor neurons are found in Sema3B null mouse embryos. In contrast, Sema6A null mice display an ectopic motor neuron phenotype. Finally, knockdown of MICAL3, a downstream semaphorin/Plexin-A signalling molecule, in chick motor neurons led to their ectopic positioning in the PNS. Conclusion: We conclude that semaphorin-mediated repellent interactions between boundary cap cells and immature spinal motor neurons regulates somal positioning by countering the drag exerted on motor neuron cell bodies by their axons as they emerge from the CNS at motor exit points. Our data support a model in which BC cell semaphorins signal through Npn-2 and/or Plexin-A2 receptors on motor neurons via a cytoplasmic effector, MICAL3, to trigger cytoskeletal reorganisation. This leads to the disengagement of somal migration from axon extension and the confinement of motor neuron cell bodies to the spinal cord.

1 February 2003 in Neuron
Verified
Journal Article
Closed access
MVMatthieu Vermeren
Matthieu Vermeren
GMGéraldine S. Maro
Géraldine S. Maro
RBRomke Bron
Romke Bron
IMImelda Mary McGonnell
Imelda Mary McGonnell
PCPatrick Charnay
Patrick Charnay
JCJames Cohen
James Cohen

1 May 2017 in The American Journal of Human Genetics
Verified
Journal Article
Open access
EHEmma A. Hall
Emma A. Hall
MNMichael S. Nahorski
Michael S. Nahorski
LMLyndsay M. Murray
Lyndsay M. Murray
RSRanad Shaheen
Ranad Shaheen
EPEmma Perkins
Emma Perkins
PMPleasantine Mill
Pleasantine Mill
During neurotransmission, synaptic vesicles undergo multiple rounds of exo-endocytosis, involving recycling and/or degradation of synaptic proteins. While ubiquitin signaling at synapses is essential for neural function, it has been assumed that synaptic proteostasis requires the ubiquitin-proteasome system (UPS). We demonstrate here that turnover of synaptic membrane proteins via the endolysosomal pathway is essential for synaptic function. In both human and mouse, hypomorphic mutations in the ubiquitin adaptor protein PLAA cause an infantile-lethal neurodysfunction syndrome with seizures. Resulting from perturbed endolysosomal degradation, Plaa mutant neurons accumulate K63-polyubiquitylated proteins and synaptic membrane proteins, disrupting synaptic vesicle recycling and neurotransmission. Through characterization of this neurological intracellular trafficking disorder, we establish the importance of ubiquitin-mediated endolysosomal trafficking at the synapse.

22 April 2004 in Developmental Dynamics
Verified
Journal Article
Open access
PDF file
RBRomke Bron
Romke Bron
BEBritta J. Eickholt
Britta J. Eickholt
MVMatthieu Vermeren
Matthieu Vermeren
NFNinfa Fragale
Ninfa Fragale
JCJames Cohen
James Cohen
The chick embryo is widely used for the study of vertebrate development, but a general, reliable loss‐of‐function strategy for the analysis of gene function is currently not available. By using small inhibitory hairpin RNA (siRNA) molecules generated by the mouse U6 promoter, we have applied an RNA interference approach to achieve quantitative knockdown of the neuropilin‐1 (Nrp‐1) receptor in chick embryos. Functional knockdown was evident in the abolition of Sema3A‐induced growth cone collapse in Nrp‐1‐siRNA but not Nrp‐2‐siRNA–expressing dorsal root ganglion (DRG) neurons. Two nervous system defects in Nrp‐1 mutant mice were phenocopied in embryos treated with Nrp‐1 siRNA. First, DRG axons prematurely entered the dorsal horn and projected inappropriately. Second, targeted early migrating neural crest cells destined for the sympathetic chain arrested ectopically within ventral spinal nerve roots. Localized knockdown induced by specific siRNA constructs will allow rapid functional analysis of genes regulating chick neural development whilst circumventing embryonic lethal effects often associated with global gene knockout in the mouse. Developmental Dynamics 230:299–308, 2004.

24 October 2017 in Science Signaling
Verified
Journal Article
Closed access
PDF file
SCSiobhan Ni Choileain
Siobhan Ni Choileain
JHJoanne Hay
Joanne Hay
JTJoelle Thomas
Joelle Thomas
AWAnna Williams
Anna Williams
MVMatthieu M. Vermeren
Matthieu M. Vermeren
AAAnne L. Astier
Anne L. Astier
A lack of regulatory T cell function is a critical factor in the pathogenesis of autoimmune diseases, such as multiple sclerosis (MS). Ligation of the complement regulatory protein CD46 facilitates the differentiation of T helper 1 (TH1) effector cells into interleukin-10 (IL-10)–secreting type 1 regulatory T cells (Tr1 cells), and this pathway is defective in MS patients. Cleavage of the ectodomain of CD46, which contains three N-glycosylation sites and multiple O-glycosylation sites, enables CD46 to activate T cells. We found that stimulation of the T cell receptor (TCR)–CD3 complex was associated with a reduction in the apparent molecular mass of CD46 in a manner that depended on O-glycosylation. CD3-stimulated changes in CD46 O-glycosylation status reduced CD46 processing and subsequent T cell signaling. During T cell activation, CD46 was recruited to the immune synapse in a manner that required its serine-, threonine-, and proline-rich (STP) region, which is rich in O-glycosylation sites. Recruitment of CD46 to the immune synapse switched T cells from producing the inflammatory cytokine interferon-γ (IFN-γ) to producing IL-10. Furthermore, CD4+ T cells isolated from MS patients did not exhibit a CD3-stimulated reduction in the mass of CD46 and thus showed increased amounts of cell surface CD46. Together, these data suggest a possible mechanism underlying the regulatory function of CD46 on T cells. Our findings may explain why this pathway is defective in patients with MS and provide insights into MS pathogenesis that could help to design future immunotherapies.